Related Experiment Video
Updated: May 25, 2026
06:24
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
MUC1 regulates PDGFA expression during pancreatic cancer progression
M Sahraei1, L D Roy, J M Curry
1Department of Biology, University of North Carolina, Charlotte, NC 28223, USA.
Oncogene
|January 24, 2012
Summary
Mucin 1 (MUC1) drives pancreatic cancer growth by regulating platelet-derived growth factor-A (PDGFA). Targeting this MUC1-PDGFA interaction offers a potential therapeutic strategy for pancreatic ductal adenocarcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic ductal adenocarcinoma (PDA) exhibits a poor prognosis.
- Mucin 1 (MUC1) is implicated in cancer progression, but its precise role in PDA is unclear.
- Platelet-derived growth factor-A (PDGFA) is a known driver of PDA growth and metastasis.
Purpose of the Study:
- To investigate the novel association between MUC1 and PDGFA in PDA.
- To elucidate the mechanism by which MUC1 influences PDGFA expression and secretion.
- To determine the therapeutic potential of targeting the MUC1-PDGFA pathway in PDA.
Main Methods:
- Utilized mouse PDA models and human patient samples.
- Investigated MUC1's regulation of PDGFA expression and secretion.
- Examined the role of MUC1 and PDGFA in cancer cell proliferation, invasion, and nuclear β-catenin translocation.
- Elucidated the mechanism involving MUC1, Hif1-α, and PDGFA regulation.
Main Results:
- MUC1 directly regulates PDGFA expression and secretion in pancreatic cancer cells.
- MUC1-overexpressing cells show a dependency on PDGFA for proliferation and invasion.
- MUC1 and PDGFA are critical for β-catenin nuclear translocation, promoting oncogenesis.
- MUC1 facilitates Hif1-α translocation, thereby controlling PDGFA expression.
Conclusions:
- MUC1 promotes PDA invasion and proliferation through increased PDGFA production.
- The MUC1-PDGFA signaling axis is a key oncogenic pathway in PDA.
- Inhibiting MUC1's regulation of PDGFA presents a promising therapeutic avenue for PDA patients.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...